Table 1.
Characteristics of development and validation data sets.
|
|
|
NESDAa (n=125) | MOOVDb (n=54) | ||||||||
|
|
|
Depressed (n=43) | Control (n=82) | Depressed (n=27) | Control (n=27) | ||||||
| Study characteristics |
|
|
|
|
|||||||
|
|
Data collection period | 2014-2017 | 2012-2014 | ||||||||
|
|
Setting | General population, primary health care, and mental health care | General population, and outpatient centers for psychiatry | ||||||||
|
|
Inclusion criteria for cases | Receiving a depression diagnosis 1 month before the ESMc/actigraphy assessment | Receiving a depression diagnosis 1 month before the ESM/actigraphy assessment | ||||||||
|
|
Outcome | Presence or absence of a depression diagnosis (MDDd and/or dysthymia) based on DSM-IVe criteria | Presence or absence of a depression diagnosis (MDD and/or dysthymia) based on DSM-IV criteria | ||||||||
|
|
Prevalence of outcome, n (%) | 43 (34.4) | 27 (50.0) | ||||||||
| Sociodemographic characteristics |
|
|
|||||||||
|
|
Female, n (%) | 29 (67.4) | 46 (56.1) | 20 (74.1) | 20 (74.1) | ||||||
|
|
Age, mean (SD) | 52.14 (9.57) | 51.50 (12.70) | 34.70 (9.86) | 34.04 (8.96) | ||||||
|
|
Education (high), n (%) | 13 (30.2) | 49 (59.8) | 17 (63.0) | 19 (70.4) | ||||||
| Psychopathology |
|
|
|
|
|||||||
|
|
Depression severity instrument | IDS-SRf | BDI-IIg | ||||||||
|
|
Depression severity, mean (range) | 34.53 (9-64) | 5.44 (0-25) | 31.33 (15-51) | 2.26 (0-10) | ||||||
|
|
ADh and/or BDi use, n (%) | 23 (53.5) | 4 (4.9) | 15 (55.6) | 1 (3.7) | ||||||
aNESDA: the Netherlands Study of Depression and Anxiety.
bMOOVD: Mood and Movement in Daily Life.
cESM: experience sampling method.
dMDD: major depressive disorder.
eDSM-IV: Diagnostic and Statistical Manual of Mental Disorders, fourth edition.
fIDS-SR: Inventory of Depressive Symptomatology (self-report).
gBDI-II: Beck Depression Inventory-II.
hAD: antidepressant.
iBD: benzodiazepine.